Notice: This company has been marked as potentially delisted and may not be actively trading. NASDAQ:EYEG AB Corporate Bond ETF (EYEG) Price, Holdings, & News Add Compare Share Share Stock Analysis Stock AnalysisDividendHeadlinesShort InterestTrends About AB Corporate Bond ETF (NASDAQ:EYEG) 30 days 90 days 365 days Advanced Chart Ad Paradigm Press[Urgent] Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again with Tesla… which is up more than 19,500% since 2010. For perspective, that turns $100 invested into almost $20,000! And now, Elon could be set to do it for the third and final time… with what might be his biggest breakthrough yet. And for the first time ever, you have the rare chance to profit BEFORE the upcoming IPO.Click here now for the urgent details on this hidden play. Get AB Corporate Bond ETF alerts:Sign Up Key Stats Today's Range$35.73▼$35.7350-Day Range$1.59▼$2.2552-Week Range$1.44▼$8.18Volume1 shsAverage Volume935,975 shsMarket Capitalization$25.01 millionAssets Under Management$24.93 millionDividend Yield1.97%Net Expense Ratio0.30%Aggregate RatingN/A ETF OverviewEyeGate Pharmaceuticals, Inc. is a clinical stage specialty pharmaceutical company, which engages in the development and commercialization of products for treating diseases and disorders of the eye. Its pipeline includes MoxiGel and Ocular Bandage Gel. The company was founded in 1998 and is headquartered in Waltham, MA.Read More… [Urgent] Starlink Set For The Largest IPO In History? (Ad)He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again with Tesla… which is up more than 19,500% since 2010. For perspective, that turns $100 invested into almost $20,000! And now, Elon could be set to do it for the third and final time… with what might be his biggest breakthrough yet. And for the first time ever, you have the rare chance to profit BEFORE the upcoming IPO.Click here now for the urgent details on this hidden play. AB Corporate Bond ETF ExpensesTypeEYEGInvestment Grade ETFsFixed Income ETFsNASDAQ ETFsAll ETFsManagement Fee0.30%0.22%0.33%0.49%0.52%Other Expenses0.00%0.12%0.26%0.41%0.53%Total Expense0.30%0.25%0.40%0.63%0.71%Fee Waiver0.00%-0.14%-0.25%-0.32%-0.57%Net Expense0.30%0.23%0.36%0.56%0.59% Receive EYEG Stock News and Ratings via Email Sign-up to receive the latest news and ratings for AB Corporate Bond ETF and its competitors with MarketBeat's FREE daily newsletter. Email Address EYEG ETF News HeadlinesGoldman Sachs Access High Yield Corporate Bond ETF declares monthly distribution of $0.2568November 4, 2024 | msn.comVanguard ESG U.S. Corporate Bond ETF declares monthly distribution of $0.2408November 1, 2024 | msn.comWhat do “they” know that you don’t?Over the past decade, the Central Bank trade has been clear: Sell Treasuries, buy gold. In fact, Central Banks have now DOUBLED their gold stake - sending stockpiles to the highest level since the '90s, according to The Kobeissi Letter.November 22, 2024 | Stansberry Research (Ad)What Economic Factors Influence Corporate Bond Yields?October 30, 2024 | investopedia.comBUFC AB Conservative Buffer ETFOctober 27, 2024 | seekingalpha.comHigh Yield Corporate Bonds In Emerging Markets Are Red HotOctober 22, 2024 | seekingalpha.comSee More Headlines EYEG ETF - Frequently Asked Questions How were AB Corporate Bond ETF's earnings last quarter? AB Corporate Bond ETF (NASDAQ:EYEG) issued its quarterly earnings data on Thursday, August, 12th. The specialty pharmaceutical company reported ($0.35) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.42) by $0.07. When did AB Corporate Bond ETF IPO? AB Corporate Bond ETF (EYEG) raised $5 million in an IPO on Friday, February 13th 2015. The company issued 800,000 shares at a price of $6.00 per share. Aegis Capital Corp and Chardan Capital Markets served as the underwriters for the IPO. What other stocks do shareholders of AB Corporate Bond ETF own? Based on aggregate information from My MarketBeat watchlists, some other companies that AB Corporate Bond ETF investors own include Bausch Health Companies (BHC), MannKind (MNKD), Bristol-Myers Squibb (BMY), Sorrento Therapeutics (SRNE), Idera Pharmaceuticals (IDRA), SCYNEXIS (SCYX) and Novavax (NVAX). Fund Details IssuerAllianceBernstein Fund NameAB Corporate Bond ETF Tax ClassificationRegulated Investment Company Stock ExchangeNASDAQCurrent SymbolNASDAQ:EYEG Inception Date12/13/2023 Fund ManagerTimothy Kurpis, Bernd Wuebben Webwww.eyegatepharma.com Phone(781) 788-8869Fund Focus Asset ClassFixed Income BenchmarkN/A CategoryCorporate FocusInvestment Grade Development LevelBlended Development RegionGlobal Number of Holdings403 Fund Statistics Assets Under Management$24.95 million Average Daily Volume$0.00 Discount/Premium0.10% Administrator, Advisor and Custodian AdministratorState Street Bank and Trust Company AdvisorAllianceBernstein L.P. CustodianState Street Bank and Trust Company DistributorForeside Fund Services, LLC Transfer AgentState Street Bank and Trust Company TrusteeN/A Lead Market MakerJane Street Options OptionableN/A Short Interest1,100 shs Miscellaneous Outstanding Shares700,000Beta0.16 Creation Unit50,000 Creation Fee$250.00 A Guide To High-Short-Interest StocksMarketBeat's analysts have just released their top five short plays for December 2024. Learn which stocks have the most short interest and how to trade them. Click the link below to see which companies made the list.Get This Free Report This page (NASDAQ:EYEG) was last updated on 11/22/2024 by MarketBeat.com Staff From Our Partners[Urgent] Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it a...Paradigm Press | SponsoredTrump’s Victory Just Kicked the Door Open to a…This story is about a division that has been splitting America apart at the seams for the past three and a hal...Banyan Hill Publishing | SponsoredBuffett Dumps $982 Million in BofA Stock—What Does He Know?Buffett's been eerily quiet about his reasons, but his actions speak volumes. When someone with his track reco...Genesis Gold Group | SponsoredCentral Bank Abandons USDYou know what doesn't care about elections? Gold. If you want to protect your savings & retirement from our...Desko Digital | SponsoredA “Thank You Gift” From Pres. Trump - GeniusThe "Fake Media" has completely ignored Trump's genius "victory gift" to all America First patriots like you. ...Colonial Metals | Sponsored[625,000% Gain] – Are You Ready for the Next Altcoin Boom?All of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you k...Crypto Swap Profits | SponsoredWhat Comes Next Could Be a Once-in-a-Lifetime OpportunityA wave of technological and financial transformation is reshaping the investment landscape. For those who unde...InvestorPlace | SponsoredCan Trump Make Housing Great Again?Trump won. But can he undo the damage the Democrats have inflicted on this nation? Under Biden, inflatio...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding AB Corporate Bond ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share AB Corporate Bond ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free EYEG Stock Alerts